FES PET/CT

DIAGNOSTIC_TEST2 trials

Sponsors

Institut Cancerologie de l'Ouest, University of Wisconsin, Madison

Conditions

ERα+ Breast CancerESR1 Gene MutationMetastatic Breast Cancer

Early Phase 1

FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer

RecruitingNCT04174352

University of Wisconsin, MadisonERα+ Breast Cancer, ESR1 Gene Mutation

Start: 2020-10-20End: 2027-12-01Target: 12Updated: 2026-07-21

Unknown Phase

Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer

Active, not recruitingNCT03442504

Institut Cancerologie de l'OuestMetastatic Breast Cancer

Start: 2017-03-15End: 2024-06-30Updated: 2024-03-12